| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $457.4M | -49.9% |
| R&D Expense | $26.2M | -58.3% |
| SG&A Expense | $249.0M | -52.5% |
| Operating Income | -$30.9M | +67.5% |
| Interest Expense | $20.2M | +10.7% |
| Pre-tax Income | -$50.8M | +53.7% |
| Income Tax | $5.2M | +111.3% |
| Net Income | -$393.3M | -515.6% |
| EPS (Basic) | -$14.87 | -506.9% |
| EPS (Diluted) | -$14.87 | -506.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.5M | -20.2% |
| Accounts Receivable | $65.2M | -61.4% |
| Inventory | $79.6M | -66.0% |
| Current Assets | $482.9M | -10.2% |
| Total Assets | $1.21B | -26.6% |
| Current Liabilities | $173.6M | -20.1% |
| Long-term Debt | $511.9M | -3.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $37.1M | +50.8% |
| Investing Cash Flow | -$15.2M | +47.1% |
| Financing Cash Flow | -$25.7M | -1863.7% |
| Total Liabilities |
| $795.9M |
| -9.9% |
| Stockholders' Equity | $409.5M | -46.0% |